Opexa Therapeutics Overview
- Year Founded
-
2001

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$7.01M
Opexa Therapeutics General Information
Description
Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The company's personalized cellular immunotherapy treatment is in late stage clinical development targeting both Secondary Progressive and Relapsing Remitting MS, aligning the interests of patients, employees and shareholders.
Contact Information
Website
www.opexatherapeutics.comCorporate Office
- 2635 Technology Forest Boulevard
- The Woodlands, TX 77381
- United States
Corporate Office
- 2635 Technology Forest Boulevard
- The Woodlands, TX 77381
- United States
Opexa Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Merger/Acquisition | 19-Sep-2017 | $7.01M | Completed | Profitable | ||
9. 2PO | 07-Aug-2013 | Completed | Profitable | |||
8. Debt - General | 15-Feb-2013 | Completed | Profitable | |||
7. PIPE | 16-Nov-2012 | Completed | Profitable | |||
6. PIPE | Completed | Profitable | ||||
5. Convertible Debt | 01-May-2009 | Completed | Profitable | |||
4. PIPE | 13-Apr-2008 | Completed | Profitable | |||
3. Accelerator/Incubator | 01-Jan-2008 | Completed | Profitable | |||
2. IPO | 14-Apr-2004 | Completed | Profitable | |||
1. Early Stage VC | 01-Feb-2001 | Completed | Profitable |
Opexa Therapeutics Comparisons
Industry
Financing
Details
Opexa Therapeutics Competitors (57)
One of Opexa Therapeutics’s 57 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
MediGene | Formerly VC-backed | Planegg, Germany |
Opexa Therapeutics Patents
Opexa Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2759572-A1 | Isolation and identification of t cells | Inactive | 08-Aug-2002 | ||
AU-2003258090-B2 | Isolation and identification of t cells | Inactive | 08-Aug-2002 | ||
AU-2003258090-A1 | Isolation and identification of t cells | Active | 08-Aug-2002 | ||
CA-2492848-A1 | Isolation and identification of t cells | Active | 08-Aug-2002 | ||
ES-2545736-T3 | Isolation and identification of t cells | Inactive | 08-Aug-2002 | G01N33/53 |
Opexa Therapeutics Former Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
BCM Ventures | Venture Capital | Minority | ||
Diker Management | Hedge Fund | Minority | ||
Houston Technology Center | Accelerator/Incubator | Minority | ||
Lehman Brothers | Other Private Equity | Minority | ||
Lincoln Park Capital | Asset Manager | Minority |
Opexa Therapeutics Acquisitions (1)
Opexa Therapeutics’s most recent deal was a Reverse Merger with Acer Therapeutics. The deal was made on 19-Sep-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Acer Therapeutics | 19-Sep-2017 | Reverse Merger | Drug Discovery |
Opexa Therapeutics FAQs
-
When was Opexa Therapeutics founded?
Opexa Therapeutics was founded in 2001.
-
Where is Opexa Therapeutics headquartered?
Opexa Therapeutics is headquartered in The Woodlands, TX.
-
What industry is Opexa Therapeutics in?
Opexa Therapeutics’s primary industry is Biotechnology.
-
Is Opexa Therapeutics a private or public company?
Opexa Therapeutics is a Private company.
-
What is the current valuation of Opexa Therapeutics?
The current valuation of Opexa Therapeutics is
. -
What is Opexa Therapeutics’s current revenue?
The current revenue for Opexa Therapeutics is
. -
How much funding has Opexa Therapeutics raised over time?
Opexa Therapeutics has raised $22.9M.
-
Who are Opexa Therapeutics’s investors?
BCM Ventures, Diker Management, Houston Technology Center, Lehman Brothers, and Lincoln Park Capital are 5 of 6 investors who have invested in Opexa Therapeutics.
-
Who are Opexa Therapeutics’s competitors?
NexImmune, Intellia Therapeutics, Sorrento Therapeutics, Kite Pharma, and MediGene are some of the 57 competitors of Opexa Therapeutics.
-
When was Opexa Therapeutics acquired?
Opexa Therapeutics was acquired on 19-Sep-2017.
-
Who acquired Opexa Therapeutics?
Opexa Therapeutics was acquired by Acer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »